Compounds > n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide
Page last updated: 2024-09-03

n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide and Heart Disease, Ischemic

n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunch, FT; Cohen, MV; Downey, JM; Thornton, J1

Other Studies

1 other study(ies) available for n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide and Heart Disease, Ischemic

ArticleYear
Adenosine is an endogenous protectant against stunning during repetitive ischemic episodes in the heart.
    American heart journal, 1992, Volume: 124, Issue:6

    Topics: Adenosine; Animals; Female; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Purinergic Antagonists; Purines; Rabbits; Sulfonamides

1992